CelSci (CVM)
(Delayed Data from AMEX)
$1.08 USD
-0.02 (-1.82%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.08 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for CelSci Corporation falls in the month of September.
All items in Millions except Per Share data.
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 4 | 23 | 42 | 16 | 8 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 2 | 1 | 1 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 7 | 25 | 45 | 18 | 10 |
Net Property & Equipment | 10 | 12 | 14 | 6 | 16 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 0 | 2 | 2 | 2 |
Total Assets | 31 | 51 | 76 | 41 | 28 |
Liabilities & Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 2 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 2 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1 | 1 | 1 | 1 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 1 | 1 | 1 |
Total Current Liabilities | 6 | 5 | 4 | 4 | 3 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 10 | 12 | 13 | 12 | 14 |
Other Non-Current Liabilities | 0 | 0 | 0 | 4 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 17 | 18 | 19 | 21 | 22 |
Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 500 | 487 | 474 | 401 | 359 |
Retained Earnings | -487 | -455 | -418 | 0 | -354 |
Other Equity | 0 | 0 | 0 | -382 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 13 | 32 | 57 | 20 | 5 |
Total Liabilities & Shareholder's Equity | 31 | 51 | 76 | 41 | 28 |
Total Common Equity | 13 | 32 | 57 | 20 | 5 |
Shares Outstanding | 47.20 | 43.30 | 43.00 | 38.60 | 34.80 |
Book Value Per Share | 0.28 | 0.74 | 1.31 | 0.51 | 0.15 |
Fiscal Year End for CelSci Corporation falls in the month of September.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 0 | 5 | 3 | 4 | 5 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 2 | 2 | 2 | 2 |
Other Current Assets | 1 | 1 | 1 | 1 | 0 |
Total Current Assets | 4 | 9 | 6 | 7 | 8 |
Net Property & Equipment | 9 | 9 | 10 | 10 | 11 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 2 | 2 | 2 | 2 |
Total Assets | 24 | 30 | 29 | 31 | 32 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 2 | 2 | 2 | 2 | 2 |
Accrued Expenses | 1 | 1 | 1 | 1 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 6 | 5 | 5 | 6 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 8 | 9 | 9 | 10 | 10 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 16 | 16 | 16 | 17 | 18 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 0 | 0 |
Capital Surplus | 516 | 515 | 506 | 500 | 494 |
Retained Earnings | -508 | -501 | -494 | -487 | -479 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 8 | 14 | 13 | 13 | 15 |
Total Liabilities & Shareholder's Equity | 24 | 30 | 29 | 31 | 32 |
Total Common Equity | 8 | 14 | 13 | 13 | 15 |
Shares Outstanding | 54.20 | 53.90 | 49.90 | 47.20 | 47.20 |
Book Value Per Share | 0.16 | 0.27 | 0.25 | 0.28 | 0.31 |